Connect with us

Hi, what are you looking for?

SecurityWeekSecurityWeek

Cybercrime

Ransomware Operators Threaten to Leak 1.5TB of Supernus Pharmaceuticals Data

Biopharmaceutical company Supernus Pharmaceuticals last week confirmed it fell victim to a ransomware attack that resulted in a large amount of data being exfiltrated from its network.

Biopharmaceutical company Supernus Pharmaceuticals last week confirmed it fell victim to a ransomware attack that resulted in a large amount of data being exfiltrated from its network.

The attack, the Rockville, Maryland-based company says, likely happened in mid-November, when a ransomware group accessed data on certain systems, deployed malware to prevent access to files, and then threatened to leak the exfiltrated files.

Despite that, Supernus Pharmaceuticals says it did not experience a significant impact on its business, as its operations were not seriously disrupted by the incident.

“The Company continues to operate without interruption and does not currently anticipate paying any ransom amounts to any criminal ransomware group,” the company says.

Supernus Pharmaceuticals also notes that it was able to recover the impacted files and that it took steps to improve the security of its network and files.

“To date, the Company has not paid any ransom and has been able to restore all of the information encrypted by the criminal ransomware group,” Supernus Pharmaceuticals underlined.

Advertisement. Scroll to continue reading.

However, the company does believe that the miscreants will likely attempt to exploit the improperly obtained information.

On Thanksgiving, the Hive ransomware group claimed responsibility for the attack, saying that it breached Supernus Pharmaceuticals’ network on November 14, and that it managed to exfiltrate a total of 1,268,906 files, totaling 1.5 terabytes of data.

The hacking group announced on their leaks website on the Tor network that the stolen information will be posted online soon, pointing out that the company failed to mention the incident in their latest 8-K Form filed with the Securities and Exchange Commission (SEC).

On Friday, however, Supernus Pharmaceuticals filed another 8-K Form with the SEC, to mention the ransomware attack specifically.

Despite Supernus Pharmaceuticals’ claim that it has no plans to pay a ransom, the Hive ransomware operators claim that the company has been negotiating with them ever since the attack happened.

Related: FBI Shares IOCs for ‘Hive’ Ransomware Attacks

Related: FBI Publishes Indicators of Compromise for Ranzy Locker Ransomware

Related: Attackers Encrypt VMware ESXi Server With Python Ransomware

Written By

Ionut Arghire is an international correspondent for SecurityWeek.

Daily Briefing Newsletter

Subscribe to the SecurityWeek Email Briefing for the latest cybersecurity threats, trends, and expert insights.

Click to comment

You must be logged in to post a comment Login

Leave a Reply

Daily Briefing Newsletter

Subscribe to the SecurityWeek Email Briefing to stay informed on the latest threats, trends, and technology, along with insightful columns from industry experts.

NOW LIVE: CISO Forum 2026 Summit

Join as we bring together CISOs, senior cybersecurity executives, practitioners, industry experts, and other security leaders to share practical experience and examine the issues shaping enterprise cybersecurity strategy.

Register

Join to learn the four levels of architecting security into the agentic SDLC – from securing the code your developers' agents write to running a coordinated system of security agents you've built yourself.

Register

People on the Move

Kirsten Davies has been appointed National Cyber Director.

Zifino has appointed Toney E. Jennings as CRO.

Zeke Maldonado has been named Principal Deputy CIO at the US Department of Commerce.

More People On The Move

Expert Insights

Daily Briefing Newsletter

Subscribe to the SecurityWeek Email Briefing to stay informed on the latest cybersecurity news, threats, and expert insights. Unsubscribe at any time.